Dynamic risk stratification in medullary thyroid carcinoma: Single institution experiences

Area of Science:

• Endocrinology
• Oncology
• Surgical Oncology

Background:

• Anatomic staging systems are traditional but may not fully capture dynamic disease progression.
• Dynamic risk stratification has shown value in nonmedullary thyroid cancer and is being adopted for medullary thyroid cancer (MTC).

Purpose of the Study:

• To compare the clinical utility of response to initial therapy stratification against the traditional anatomic staging system in MTC patients.

Main Methods:

• Retrospective review of 117 MTC patients who underwent thyroidectomy between 1982 and 2012.
• Analysis of clinicopathological features and surgical outcomes with a mean follow-up of 85.78 months.

Main Results:

• Both TNM staging and response to initial therapy provided prognostic information.
• TNM staging predicted disease-free survival (DFS), disease-specific survival (DSS), and no evidence of disease, but not biochemical recurrence.
• Response to initial therapy stratified DFS, DSS, no evidence of disease, and biochemical recurrence risk.

Conclusions:

• Dynamic risk stratification using response to initial therapy provides more comprehensive prognostic information than the anatomic staging system in MTC.
• This adjusted response to initial therapy system enhances risk assessment for MTC patients.